Search results
Fate Therapeutics (FATE) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 year agoFate Therapeutics (FATE) delivered earnings and revenue surprises of 7.53% and 2.34%, respectively,...
Fate Therapeutics, Inc.'s (NASDAQ:FATE) Low P/S No Reason For Excitement
Simply Wall St. via Yahoo Finance· 11 months agoFate Therapeutics, Inc.'s (NASDAQ:FATE) price-to-sales (or "P/S") ratio of 3.8x might make it look...
Analysts Estimate Fate Therapeutics (FATE) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 2 years agoFate Therapeutics (FATE) doesn't possess the right combination of the two key ingredients for a...
While Fate Therapeutics (NASDAQ:FATE) shareholders have made 502% in 5 years, increasing losses...
Simply Wall St. via Yahoo Finance· 2 years agoFate Therapeutics, Inc. (NASDAQ:FATE) shareholders might understandably be very concerned that the...
Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoFate Therapeutics, Inc. (NASDAQ:FATE) Q4 2022 Earnings Call Transcript February 28, 2023 Operator:...
One Fate Therapeutics Insider Raised Stake By 83% In Previous Year
Simply Wall St. via Yahoo Finance· 9 months agoViewing insider transactions for Fate Therapeutics, Inc.'s (NASDAQ:FATE ) over the last year, we see...
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 month agoA month has gone by since the last earnings report for Fate Therapeutics (FATE). Shares have lost...
Fate Therapeutics Insiders US$207k Short Of Breakeven On Stock Purchase
Simply Wall St. via Yahoo Finance· 4 months agoInsiders who bought US$698.1k worth of Fate Therapeutics, Inc. (NASDAQ:FATE) stock in the last year...
Fate Therapeutics (FATE) Upgraded to Buy: Here's Why
Zacks via Yahoo Finance· 4 months agoFate Therapeutics (FATE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Will Fate Therapeutics (NASDAQ:FATE) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 1 year agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...